The details of the RLI scheme are not yet specified, but to be eligible for the incentives, companies may be asked to invest at least 15% of their turnover in R&D.
Topics
pharmaceutical companies | biocon | Coronavirus vaccine
Sohini Das |
Last Updated Jul 3, 2022 1:28 PM IST
The Center may announce a Research Linked Incentive (RLI) program for the pharmaceutical industry to increase contribution to research and development (R&D) and move up the innovation value chain, it said. sources close to the development.
TO READ THE FULL STORY, SUBSCRIBE NOW FOR JUST RS 249 PER MONTH.
Key stories on business-standard.com are only available to premium subscribers.
Already a premium subscriber? LOGIN NOW
SUBSCRIBE TO PERSPECTIVES
What do you get on Business Standard Premium?
Dear reader,
Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.
As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.
Support quality journalism and subscribe to Business Standard.
digital editor
First published: Sun 03 Jul 2022. 13:28 IST
